{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:21:30Z","timestamp":1772133690175,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11255-020-02704-7","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T22:03:09Z","timestamp":1609711389000},"page":"1839-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9757-5059","authenticated-orcid":false,"given":"Simge","family":"Acar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2737-9060","authenticated-orcid":false,"given":"Sueda","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-6137","authenticated-orcid":false,"given":"Cinar","family":"Oztosun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1369-3657","authenticated-orcid":false,"given":"Baris","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3106-0458","authenticated-orcid":false,"given":"Alan A.","family":"Sag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4601-8164","authenticated-orcid":false,"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-2486","authenticated-orcid":false,"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"issue":"6","key":"2704_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cardfail.2013.04.002","volume":"19","author":"MM Givertz","year":"2013","unstructured":"Givertz MM, Teerlink JR, Albert NM, Westlake Canary CA, Collins SP, Colvin-Adams M et al (2013) Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail 19(6):371\u2013389","journal-title":"J Card Fail"},{"issue":"3","key":"2704_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jchf.2019.10.012","volume":"8","author":"M Griffin","year":"2020","unstructured":"Griffin M, Soufer A, Goljo E, Colna M, Rao VS, Jeon S et al (2020) Real world use of hypertonic saline in refractory acute decompensated heart failure: A U.S. Center\u2019s experience. JACC Heart Fail 8(3):199\u2013208","journal-title":"JACC Heart Fail"},{"issue":"3","key":"2704_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","volume":"12","author":"JM ter Maaten","year":"2015","unstructured":"ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA (2015) Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol 12(3):184\u2013192","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","volume":"9","author":"V Hasselblad","year":"2007","unstructured":"Hasselblad V, GattisStough W, Shah MR, Lokhnygina Y, O\u2019Connor CM, Califf RM et al (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9(10):1064\u20131069","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2704_CR5","first-page":"335","volume":"47","author":"I Nistor","year":"2015","unstructured":"Nistor I, Bararu I, Apavaloaie MC, Voroneanu L, Donciu MD, Kanbay M et al (2015) Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials. Int UrolNephrol 47(2):335\u2013344","journal-title":"Int UrolNephrol"},{"issue":"6","key":"2704_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10741-017-9619-2","volume":"22","author":"B Afsar","year":"2017","unstructured":"Afsar B, Rossignol P, van Heerebeek L, Paulus WJ, Damman K, Heymans S et al (2017) Heart failure with preserved ejection fraction: a nephrologist-directed primer. Heart Fail Rev 22(6):765\u2013773","journal-title":"Heart Fail Rev"},{"issue":"11","key":"2704_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jchf.2018.06.017","volume":"6","author":"JE Strobeck","year":"2018","unstructured":"Strobeck JE, Feldschuh J, Miller WL (2018) Heart failure outcomes with volume-guided management. JACC Heart Fail 6(11):940\u2013948","journal-title":"JACC Heart Fail"},{"issue":"3","key":"2704_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.hfc.2017.02.001","volume":"13","author":"K Dharmarajan","year":"2017","unstructured":"Dharmarajan K, Rich MW (2017) Epidemiology, pathophysiology, and prognosis of heart failure in older adults. Heart Fail Clin 13(3):417\u2013426","journal-title":"Heart Fail Clin"},{"issue":"1","key":"2704_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000487702","volume":"46","author":"C Ekinci","year":"2018","unstructured":"Ekinci C, Karabork M, Siriopol D, Dincer N, Covic A, Kanbay M (2018) Effects of volume overload and current techniques for the assessment of fluid status in patients with renal disease. Blood Purif 46(1):34\u201347","journal-title":"Blood Purif"},{"issue":"2","key":"2704_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2165\/00003495-199855020-00001","volume":"55","author":"TP Dormans","year":"1998","unstructured":"Dormans TP, Gerlag PG, Russel FG, Smits P (1998) Combination diuretic therapy in severe congestive heart failure. Drugs 55(2):165\u2013172","journal-title":"Drugs"},{"issue":"19","key":"2704_CR11","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","volume":"137","author":"T Ahmad","year":"2018","unstructured":"Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH et al (2018) Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation 137(19):2016\u20132028","journal-title":"Circulation"},{"issue":"1","key":"2704_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","volume":"13","author":"SW Oh","year":"2015","unstructured":"Oh SW, Han SY (2015) Loop diuretics in clinical practice. Electrolyte Blood Press 13(1):17\u201321","journal-title":"Electrolyte Blood Press"},{"issue":"11","key":"2704_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.repc.2018.03.014","volume":"37","author":"SI Jardim","year":"2018","unstructured":"Jardim SI, Ramos Dos Santos L, Araujo I, Marques F, Branco P, Gaspar A et al (2018) A 2018 overview of diuretic resistance in heart failure. Rev Port Cardiol 37(11):935\u2013945","journal-title":"Rev Port Cardiol"},{"issue":"10","key":"2704_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1586\/14779072.2015.1087313","volume":"13","author":"M Vaduganathan","year":"2015","unstructured":"Vaduganathan M, Kumar V, Voors AA, Butler J (2015) Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response. Expert Rev CardiovascTher 13(10):1075\u20131078","journal-title":"Expert Rev CardiovascTher"},{"issue":"1","key":"2704_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cardfail.2015.07.007","volume":"22","author":"JL Grodin","year":"2016","unstructured":"Grodin JL, Stevens SR, de Las FL, Kiernan M, Birati EY, Gupta D et al (2016) Intensification of medication therapy for cardiorenal syndrome in acute decompensated heart failure. J Card Fail 22(1):26\u201332","journal-title":"J Card Fail"},{"issue":"48","key":"2704_CR16","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/eurheartj\/ehu320","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Tang WH, Testani JM, McMurray JJ (2014) Terminology and definition of changes renal function in heart failure. Eur Heart J 35(48):3413\u20133416","journal-title":"Eur Heart J"},{"issue":"Suppl 4","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","volume":"39","author":"S Ljungman","year":"1990","unstructured":"Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 39(Suppl 4):10\u201321 (discussion 2-4)","journal-title":"Drugs."},{"issue":"9","key":"2704_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797\u2013805","journal-title":"N Engl J Med"},{"issue":"7","key":"2704_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589\u2013596","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2704_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","volume":"36","author":"K Damman","year":"2015","unstructured":"Damman K, Testani JM (2015) The kidney in heart failure: an update. Eur Heart J 36(23):1437\u20131444","journal-title":"Eur Heart J"},{"key":"2704_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ahj.2018.07.019","volume":"204","author":"M Fudim","year":"2018","unstructured":"Fudim M, Loungani R, Doerfler SM, Coles A, Greene SJ, Cooper LB et al (2018) Worsening renal function during decongestion among patients hospitalized for heart failure: findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial. Am Heart J 204:163\u2013173","journal-title":"Am Heart J"},{"issue":"1","key":"2704_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","volume":"5","author":"M Metra","year":"2012","unstructured":"Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V et al (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5(1):54\u201362","journal-title":"Circ Heart Fail"},{"issue":"7","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.repc.2017.10.015","volume":"37","author":"JL Martins","year":"2018","unstructured":"Martins JL, Santos L, Faustino A, Viana J, Santos J (2018) Worsening or \u2018pseudo-worsening\u2019 renal function? The prognostic value of hemoconcentration in patients admitted with acute heart failure. Rev Port Cardiol 37(7):595\u2013602","journal-title":"Rev Port Cardiol"},{"issue":"3","key":"2704_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijcard.2014.04.162","volume":"174","author":"NJ Sheerin","year":"2014","unstructured":"Sheerin NJ, Newton PJ, Macdonald PS, Leung DY, Sibbritt D, Spicer ST et al (2014) Worsening renal function in heart failure: the need for a consensus definition. Int J Cardiol 174(3):484\u2013491","journal-title":"Int J Cardiol"},{"issue":"2","key":"2704_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","volume":"7","author":"JM Testani","year":"2014","unstructured":"Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7(2):261\u2013270","journal-title":"Circ Heart Fail"},{"issue":"19","key":"2704_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","volume":"35","author":"MA Valente","year":"2014","unstructured":"Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O\u2019Connor CM et al (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35(19):1284\u20131293","journal-title":"Eur Heart J"},{"issue":"2","key":"2704_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/CIRCHEARTFAILURE.112.968230","volume":"6","author":"MA Brisco","year":"2013","unstructured":"Brisco MA, Coca SG, Chen J, Owens AT, McCauley BD, Kimmel SE et al (2013) Blood urea nitrogen\/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail 6(2):233\u2013239","journal-title":"Circ Heart Fail"},{"issue":"6","key":"2704_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","volume":"16","author":"J Lindenfeld","year":"2010","unstructured":"Heart Failure Society of A, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA et al (2010) HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 16(6):e1-194","journal-title":"J Card Fail"},{"issue":"5","key":"2704_CR29","first-page":"357","volume":"129","author":"M Sokolski","year":"2019","unstructured":"Sokolski M, Zymlinski R, Sokolska JM, Biegus J, Banasiak W, Ponikowski P (2019) True worsening renal function identifies patients with acute heart failure with an ominous outcome. Pol Arch Intern Med 129(5):357\u2013360","journal-title":"Pol Arch Intern Med"},{"issue":"6","key":"2704_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/eurjhf\/hfs039","volume":"14","author":"M Dupont","year":"2012","unstructured":"Dupont M, Shrestha K, Singh D, Awad A, Kovach C, Scarcipino M et al (2012) Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 14(6):597\u2013604","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cardfail.2009.07.003","volume":"16","author":"A Aghel","year":"2010","unstructured":"Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH (2010) Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16(1):49\u201354","journal-title":"J Card Fail"},{"issue":"1","key":"2704_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/1319-2442.174071","volume":"27","author":"S Elsharawy","year":"2016","unstructured":"Elsharawy S, Raslan L, Morsy S, Hassan B, Khalifa N (2016) Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure. Saudi J Kidney Dis Transpl 27(1):49\u201354","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"2704_CR33","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ejhf.746","volume":"19","author":"M Sokolski","year":"2017","unstructured":"Sokolski M, Zymlinski R, Biegus J, Siwolowski P, Nawrocka-Millward S, Todd J et al (2017) Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure. Eur J Heart Fail 19(6):760\u2013767","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2704_CR34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/ALN.0b013e3181cded3f","volume":"112","author":"DR McIlroy","year":"2010","unstructured":"McIlroy DR, Wagener G, Lee HT (2010) Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 112(4):998\u20131004","journal-title":"Anesthesiology"},{"key":"2704_CR35","doi-asserted-by":"publisher","first-page":"854070","DOI":"10.1155\/2015\/854070","volume":"2015","author":"B Medic","year":"2015","unstructured":"Medic B, Rovcanin B, BastaJovanovic G, Radojevic-Skodric S, Prostran M (2015) Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice. Biomed Res Int 2015:854070","journal-title":"Biomed Res Int"},{"issue":"6","key":"2704_CR36","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1046\/j.1523-1755.2002.00683.x","volume":"62","author":"CP Carvounis","year":"2002","unstructured":"Carvounis CP, Nisar S, Guro-Razuman S (2002) Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 62(6):2223\u20132229","journal-title":"Kidney Int"},{"issue":"5","key":"2704_CR37","first-page":"594","volume":"26","author":"MH Goldstein","year":"1969","unstructured":"Goldstein MH, Lenz PR, Levitt MF (1969) Effect of urine flow rate on urea reabsorption in man: urea as a \u201ctubular marker.\u201d J ApplPhysiol 26(5):594\u2013599","journal-title":"J ApplPhysiol"},{"issue":"3","key":"2704_CR38","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1681\/ASN.2006101108","volume":"18","author":"RA Fenton","year":"2007","unstructured":"Fenton RA, Knepper MA (2007) Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol 18(3):679\u2013688","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2704_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.29772","volume":"68","author":"KR Patidar","year":"2018","unstructured":"Patidar KR, Kang L, Bajaj JS, Carl D, Sanyal AJ (2018) Fractional excretion of urea: a simple tool for the differential diagnosis of acute kidney injury in cirrhosis. Hepatology 68(1):224\u2013233","journal-title":"Hepatology"},{"issue":"2","key":"2704_CR40","doi-asserted-by":"publisher","first-page":"c145","DOI":"10.1159\/000254387","volume":"114","author":"CJ Diskin","year":"2010","unstructured":"Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB (2010) The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states. Nephron ClinPract 114(2):c145\u2013c150","journal-title":"Nephron ClinPract"},{"issue":"4","key":"2704_CR41","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2007.07.001","volume":"50","author":"MN Pepin","year":"2007","unstructured":"Pepin MN, Bouchard J, Legault L, Ethier J (2007) Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am J Kidney Dis 50(4):566\u2013573","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2704_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cardfail.2015.02.003","volume":"21","author":"MM Sood","year":"2015","unstructured":"Sood MM, Saeed M, Lim V, Cordova F, Komenda P, Malik A et al (2015) The urea-to-creatinine ratio is predictive of worsening kidney function in ambulatory heart failure patients. J Card Fail 21(5):412\u2013418","journal-title":"J Card Fail"},{"issue":"6","key":"2704_CR43","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/ehf2.12531","volume":"6","author":"Y Sujino","year":"2019","unstructured":"Sujino Y, Nakano S, Tanno J, Shiraishi Y, Goda A, Mizuno A et al (2019) Clinical implications of the blood urea nitrogen\/creatinine ratio in heart failure and their association with haemoconcentration. ESC Heart Fail 6(6):1274\u20131282","journal-title":"ESC Heart Fail"},{"key":"2704_CR44","doi-asserted-by":"crossref","unstructured":"Cox ZL, Sury K, Rao VS, Ivey-Miranda JB, Griffin M, Mahoney D, et al. (2020) Effect of loop diuretics on the fractional excretion of urea in decompensated heart failure. J Card Fail","DOI":"10.1016\/S0735-1097(20)31385-1"},{"issue":"6","key":"2704_CR45","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1590\/S1516-31801995000600008","volume":"113","author":"A Monteiro Pacheco Jr","year":"1995","unstructured":"Monteiro Pacheco A Jr, Martins Coimbra RS, Kreimeier U, Frey L, Messmer K (1995) Hypertonic volume therapy: feasibility in the prevention and treatment of multiple organ failure and sepsis. Sao Paulo Med J 113(6):1053\u20131060","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"2704_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00059-013-4041-6","volume":"40","author":"R De Vecchis","year":"2015","unstructured":"De Vecchis R, Esposito C, Ariano C, Cantatrione S (2015) Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: a meta-analysis of the literature. Herz 40(3):423\u2013435","journal-title":"Herz"},{"issue":"9","key":"2704_CR47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00380-018-1156-y","volume":"33","author":"T Ando","year":"2018","unstructured":"Ando T, Okuhara Y, Orihara Y, Nishimura K, Yamamoto K, Masuyama T et al (2018) Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis. Heart Vessels 33(9):1029\u20131036","journal-title":"Heart Vessels"},{"issue":"4","key":"2704_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1536\/ihj.16-313","volume":"58","author":"Y Wan","year":"2017","unstructured":"Wan Y, Li L, Niu H, Ma X, Yang J, Yuan C et al (2017) Impact of compound hypertonic saline solution on decompensated heart failure. Int Heart J 58(4):601\u2013607","journal-title":"Int Heart J"},{"issue":"6","key":"2704_CR49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/CRD.0b013e31822b4939","volume":"19","author":"R Kassamali","year":"2011","unstructured":"Kassamali R, Sica DA (2011) Acetazolamide: a forgotten diuretic agent. Cardiol Rev 19(6):276\u2013278","journal-title":"Cardiol Rev"},{"issue":"2","key":"2704_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ejhf.35","volume":"16","author":"FH Verbrugge","year":"2014","unstructured":"Verbrugge FH, Dupont M, Steels P, Grieten L, Swennen Q, Tang WH et al (2014) The kidney in congestive heart failure: \u2018are natriuresis, sodium, and diuretics really the good, the bad and the ugly?\u2019 Eur J Heart Fail 16(2):133\u2013142","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"2704_CR51","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M et al (2019) Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail 21(11):1415\u20131422","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2704_CR52","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000335117","volume":"28","author":"H Amlal","year":"2011","unstructured":"Amlal H, Soleimani M (2011) Pendrin as a novel target for diuretic therapy. Cell Physiol Biochem 28(3):521\u2013526","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"2704_CR53","first-page":"e12465","volume":"36","author":"J Nunez","year":"2018","unstructured":"Nunez J, Heredia R, Paya A, Sanchis I, Del Prado S, Minana G et al (2018) Use of acetazolamide in the treatment of patients with refractory congestive heart failure. CardiovascTher 36(6):e12465","journal-title":"CardiovascTher"},{"key":"2704_CR54","doi-asserted-by":"crossref","unstructured":"Wongboonsin J, Thongprayoon C, Bathini T, Ungprasert P, Aeddula NR, Mao MA, et al. (2019) Acetazolamide therapy in patients with heart failure: a meta-analysis. J Clin Med 8(3)","DOI":"10.3390\/jcm8030349"},{"issue":"11","key":"2704_CR55","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ejhf.1307","volume":"20","author":"W Mullens","year":"2018","unstructured":"Mullens W, Verbrugge FH, Nijst P, Martens P, Tartaglia K, Theunissen E et al (2018) Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. Eur J Heart Fail 20(11):1591\u20131600","journal-title":"Eur J Heart Fail"},{"key":"2704_CR56","doi-asserted-by":"crossref","unstructured":"Cherney DZ, Kanbay M, Lovshin JA. 2020 Renal physiology of glucose handling and therapeutic implications. Nephrol Dial Transplant. 35(Supplement_1):i3\u2013i12","DOI":"10.1093\/ndt\/gfz230"},{"issue":"4","key":"2704_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrcardio.2016.35","volume":"13","author":"I Raz","year":"2016","unstructured":"Raz I, Cahn A (2016) Heart failure: SGLT2 inhibitors and heart failure\u2014clinical implications. Nat Rev Cardiol 13(4):185\u2013186","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"2704_CR58","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"5","key":"2704_CR59","first-page":"520","volume":"85","author":"B Komoroski","year":"2009","unstructured":"Komoroski B, Vachharajani N, Boulton D, Kornhauser D, Geraldes M, Li L et al (2009) Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects. ClinPharmacolTher 85(5):520\u2013526","journal-title":"ClinPharmacolTher"},{"issue":"1","key":"2704_CR60","first-page":"5","volume":"17","author":"MV Karg","year":"2018","unstructured":"Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP et al (2018) SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. CardiovascDiabetol 17(1):5","journal-title":"CardiovascDiabetol"},{"issue":"3","key":"2704_CR61","first-page":"479","volume":"20","author":"KM Hallow","year":"2018","unstructured":"Hallow KM, Helmlinger G, Greasley PJ, McMurray JJV, Boulton DW (2018) Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes ObesMetab 20(3):479\u2013487","journal-title":"Diabetes ObesMetab"},{"issue":"5","key":"2704_CR62","first-page":"463","volume":"24","author":"SB Poulsen","year":"2015","unstructured":"Poulsen SB, Fenton RA, Rieg T (2015) Sodium-glucose cotransport. CurrOpinNephrolHypertens 24(5):463\u2013469","journal-title":"CurrOpinNephrolHypertens"},{"issue":"Suppl 2","key":"2704_CR63","first-page":"43","volume":"21","author":"JA Dominguez Rieg","year":"2019","unstructured":"Dominguez Rieg JA, Rieg T (2019) What does sodium-glucose co-transporter 1 inhibition add: prospects for dual inhibition. Diabetes ObesMetab 21(Suppl 2):43\u201352","journal-title":"Diabetes ObesMetab"},{"issue":"6","key":"2704_CR64","doi-asserted-by":"publisher","first-page":"F1201","DOI":"10.1152\/ajprenal.00111.2019","volume":"316","author":"J Nespoux","year":"2019","unstructured":"Nespoux J, Patel R, Hudkins KL, Huang W, Freeman B, Kim YC et al (2019) Gene deletion of the Na(+)-glucose cotransporter SGLT1 ameliorates kidney recovery in a murine model of acute kidney injury induced by ischemia-reperfusion. Am J Physiol Renal Physiol 316(6):F1201\u2013F1210","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"2704_CR65","first-page":"271","volume":"11","author":"N Shah","year":"2017","unstructured":"Shah N, Madanieh R, Alkan M, Dogar MU, Kosmas CE, Vittorio TJ (2017) A perspective on diuretic resistance in chronic congestive heart failure. TherAdvCardiovasc Dis 11(10):271\u2013278","journal-title":"TherAdvCardiovasc Dis"},{"issue":"12","key":"2704_CR66","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/oxfordjournals.eurheartj.a014805","volume":"17","author":"TP Dormans","year":"1996","unstructured":"Dormans TP, Gerlag PG (1996) Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 17(12):1867\u20131874","journal-title":"Eur Heart J"},{"issue":"2","key":"2704_CR67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/hrt.71.2.146","volume":"71","author":"KS Channer","year":"1994","unstructured":"Channer KS, McLean KA, Lawson-Matthew P, Richardson M (1994) Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 71(2):146\u2013150","journal-title":"Br Heart J"},{"issue":"10","key":"2704_CR68","doi-asserted-by":"publisher","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","volume":"114","author":"DH Ellison","year":"1991","unstructured":"Ellison DH (1991) The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 114(10):886\u2013894","journal-title":"Ann Intern Med"},{"key":"2704_CR69","first-page":"129","volume":"10","author":"M Goyfman","year":"2017","unstructured":"Goyfman M, Zamudio P, Jang K, Chee J, Miranda C, Butler J et al (2017) Combined aquaretic and diuretic therapy in acute heart failure. Int J NephrolRenovasc Dis 10:129\u2013134","journal-title":"Int J NephrolRenovasc Dis"},{"issue":"1","key":"2704_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10741-019-09838-6","volume":"25","author":"P Gargiulo","year":"2020","unstructured":"Gargiulo P, Marsico F, Renga F, Dell\u2019Aversana S, Esposito I, Marciano C et al (2020) The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev 25(1):1\u20137","journal-title":"Heart Fail Rev"},{"issue":"6","key":"2704_CR71","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","volume":"27","author":"SC Chng","year":"2013","unstructured":"Chng SC, Ho L, Tian J, Reversade B (2013) ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 27(6):672\u2013680","journal-title":"Dev Cell"},{"issue":"7","key":"2704_CR72","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","volume":"59","author":"A Murza","year":"2016","unstructured":"Murza A, Sainsily X, Coquerel D, Cote J, Marx P, Besserer-Offroy E et al (2016) Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions. J Med Chem 59(7):2962\u20132972","journal-title":"J Med Chem"},{"issue":"2","key":"2704_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ejhf.1366","volume":"21","author":"AA Voors","year":"2019","unstructured":"Voors AA, Kremer D, Geven C, Ter Maaten JM, Struck J, Bergmann A et al (2019) Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 21(2):163\u2013171","journal-title":"Eur J Heart Fail"},{"issue":"48","key":"2704_CR74","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1093\/eurheartj\/ehy682","volume":"39","author":"M Fudim","year":"2018","unstructured":"Fudim M, Ganesh A, Green C, Jones WS, Blazing MA, DeVore AD et al (2018) Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF. Eur Heart J 39(48):4255\u20134256","journal-title":"Eur Heart J"},{"key":"2704_CR75","doi-asserted-by":"crossref","unstructured":"Burkhoff D, Brener MI. (2020) Blood volume redistribution in chronic heart failure with splanchnic nerve blockade. JACC Heart Fail","DOI":"10.1016\/j.jchf.2020.04.009"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02704-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T14:08:10Z","timestamp":1629554890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02704-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02704-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}